Amplatzer Trevisio Intravascular Delivery System +1 more— 510(k) K260499
Substantially EquivalentABBOTT MEDICAL
FDA 510(k) clearance K260499 for Amplatzer Trevisio Intravascular Delivery System +1 more, Substantially Equivalent on 2026-03-13. Applicant: ABBOTT MEDICAL. Device class: 2.
Summary
Abbott Medical's Amplatzer Trevisio Intravascular Delivery System is filed under DQY, percutaneous catheters. The record's device name follows it with a run-together string of ATV part numbers, and the record doesn't describe the system further.
Class II, 21 CFR 870.1250. Cardiovascular is both the classification panel and the review panel, and it came in as a Special 510(k).
Abbott Medical filed from St. Paul, Minnesota. Review took 28 calendar days (February 13 to March 13, 2026).
Clearance details
- Device name as filed
- Amplatzer Trevisio Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80
- Applicant
- ABBOTT MEDICAL
- Product code
- Product code DQY
- Device class
- Class 2
- Regulation
- 21 CFR 870.1250
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- St. Paul, MN, US
Recent devices under product code DQY
view allMore clearances from ABBOTT MEDICAL
view allAdverse events under product code DQY
product code DQY- Death
- 464
- Injury
- 4,489
- Malfunction
- 13,721
- Other
- 2
- Total
- 18,676
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.